[Form 3] Genasys Inc. Initial Statement of Beneficial Ownership

Insider Trade Summary

5 transactions reported

Mixed 5 txns

Insider HERNANDEZ-MONTEON CASSANDRA L

Role Interim CFO/Secretary

Type	Security	Shares	Price	Value
holding	Stock Options (Right to buy)	--	--	--
holding	Stock Options (Right to buy)	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Options (Right to buy) — 20,000 shares (Direct); Common Stock — 6,540 shares (Direct); Common Stock — 1,913 shares (Indirect, See Footnote)

Footnotes (1)

1. Represents unvested restricted stock units. Shares held by the reporting person's spouse. The reporting person disclaims beneficial ownership of these shares except to the extent of their pecuniary interest Grant to reporting person on December 12, 2023, of options to purchase 20,000 shares of the issuer's common stock. The options vest as to 1/3 of the shares on December 12, 2024, 1/3 of the shares on December 12, 2025 and 1/3 of the shares on December 12, 2026. Grant to reporting person on December 12, 2024, of options to purchase 20,000 shares of the issuer's common stock. The options vest as to 1/3 of the shares on December 12, 2025, 1/3 of the shares on December 12, 2026 and 1/3 of the shares on December 12, 2027.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

HERNANDEZ-MONTEON CASSANDRA L

(Last) (First) (Middle)

16262 WEST BERNARDO DRIVE

(Street)

SAN DIEGO CA 92127

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/01/2025

3. Issuer Name and Ticker or Trading Symbol
Genasys Inc. [ GNSS ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Interim CFO/Secretary

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	6,540	D
Common Stock	1,166(1)	D
Common Stock	1,913	I	See Footnote(2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to buy)	(3)	12/12/2030	Common Stock	20,000	$1.7	D
Stock Options (Right to buy)	(4)	12/12/2031	Common Stock	20,000	$2.59	D

Explanation of Responses:

1. Represents unvested restricted stock units.

2. Shares held by the reporting person's spouse. The reporting person disclaims beneficial ownership of these shares except to the extent of their pecuniary interest

3. Grant to reporting person on December 12, 2023, of options to purchase 20,000 shares of the issuer's common stock. The options vest as to 1/3 of the shares on December 12, 2024, 1/3 of the shares on December 12, 2025 and 1/3 of the shares on December 12, 2026.

4. Grant to reporting person on December 12, 2024, of options to purchase 20,000 shares of the issuer's common stock. The options vest as to 1/3 of the shares on December 12, 2025, 1/3 of the shares on December 12, 2026 and 1/3 of the shares on December 12, 2027.

	/s/ Cassandra L. Hernandez-Monteon	07/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.